Arzeda Leverages Scalable Synthetic Biology Resources to Drive Computational Protein Design Platform
02 oct. 2018 08h00 HE
|
Arzeda
SEATTLE and SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, the Protein Design Company™, Twist Bioscience Corporation, TeselaGen Biotechnology Inc. and Labcyte Inc. have partnered to build...
Arzeda and BP Sign Collaborative Joint Development Agreement
02 oct. 2018 08h00 HE
|
Arzeda
SEATTLE and HOUSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design Company™, and BP announced a collaboration to develop a process for producing a renewable chemical with broad...
CORRECTION -- Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum
16 janv. 2018 18h53 HE
|
Arzeda
SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline on December 21, 2017 by Arzeda, we are advised by the company that "OP Fund" in the second paragraph should...
Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum
21 déc. 2017 13h22 HE
|
Arzeda
SEATTLE, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design CompanyTM, today announced that biotechnology veteran William “Bill” Baum has joined the company’s board of directors. Baum is a...
Arzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein Design
28 nov. 2017 14h33 HE
|
Arzeda
SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design CompanyTM, today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. ...
Arzeda Raises $12 Million in Series A Round of Funding Led by OS Fund
20 juil. 2017 07h00 HE
|
Arzeda
SEATTLE, July 20, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design Company, today announced that it had raised $12 million in a Series A round of funding led by OS Fund and including Bioeconomy...